AUTHOR=Streese Lukas , Hauser Christoph , Infanger Denis , Klee Sascha , Link Dietmar , Vilser Walthard , Hanssen Henner 

TITLE=Device-based day-to-day and observer variability to quantify dilation capacity in the retinal microcirculation

JOURNAL=Frontiers in Physiology

VOLUME=Volume 16 - 2025

YEAR=2025

URL=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2025.1663370

DOI=10.3389/fphys.2025.1663370

ISSN=1664-042X

ABSTRACT=IntroductionDynamic retinal analysis (DVA) is a validated method to quantify microvascular endothelial function. This study aimed to analyze day-to-day variability, intra- and interobserver variability and differences between two device generations.MethodsDVA was performed on two separate days and on two devices each, the DVA 2.0 and the DVA 3.0. One reader analyzed 20 signals of maximum arteriolar (aFID) and venular flicker-light induced dilation (vFID) twice to investigate intraobserver variability. A second reader independently analyzed 20 aFID and vFID signals to quantify interobserver variability. The interclass correlation coefficient (ICC) and the 95% confidence interval were used to quantify reliability.ResultsThe analysis of 26 participants (mean age 43 ± 14 years) showed moderate to good day-to-day variability for aFID (ICC 0.81 (0.57, 0.92), p = 0.037) and vFID (0.91 (0.80, 0.96), p < 0.001) of DVA 2.0 and low to moderate day-to-day variability for aFID (0.79 (0.49, 0.91), p = 0.076) and vFID (0.87 (0.61, 0.95), p = 0.022) of DVA 3.0. The analyses showed very good intraobserver (aFID and vFID: 0.999 (0.998, 1), p < 0.001) and interobserver variability (aFID: 0.997 (0.993, 0.999), p < 0.001; vFID: 0.998 (0.971, 0.995), p < 0.001). The measurements with devices DVA 2.0 and DVA 3.0 showed a moderate interdevice variability for aFID (0.76 (0.57, 0.89), p = 0.042) and vFID (0.87 (0.74, 0.93), p < 0.001). The ICC of aFID improved for day-to-day variability and interdevice variability after correcting for the baseline diameter.ConclusionConsideration of arteriolar baseline diameter variations may further improve day-to-day and interdevice variability. This work underpins the necessity for standardized methods to support clinical implementation of the method and the need to consider arteriolar baseline diameters in future research and clinical applications.